- Home
- HSIC vs BRKR Comparison
HSIC vs BRKR Comparison
Compare HSIC & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSIC
- BRKR
- Stock Information
- Founded
- HSIC 1932
- BRKR 1991
- Country
- HSIC United States
- BRKR United States
- Employees
- HSIC N/A
- BRKR N/A
- Industry
- HSIC Medical Specialities
- BRKR Biotechnology: Laboratory Analytical Instruments
- Sector
- HSIC Health Care
- BRKR Industrials
- Exchange
- HSIC Nasdaq
- BRKR Nasdaq
- Market Cap
- HSIC 8.7B
- BRKR 9.2B
- IPO Year
- HSIC 1995
- BRKR 2000
- Fundamental
- Price
- HSIC $71.27
- BRKR $61.26
- Analyst Decision
- HSIC Buy
- BRKR Buy
- Analyst Count
- HSIC 9
- BRKR 13
- Target Price
- HSIC $79.56
- BRKR $75.67
- AVG Volume (30 Days)
- HSIC 1.1M
- BRKR 1.4M
- Earning Date
- HSIC 02-25-2025
- BRKR 02-11-2025
- Dividend Yield
- HSIC N/A
- BRKR 0.33%
- EPS Growth
- HSIC N/A
- BRKR N/A
- EPS
- HSIC 2.42
- BRKR 2.06
- Revenue
- HSIC $12,499,000,000.00
- BRKR $3,241,300,000.00
- Revenue This Year
- HSIC $6.16
- BRKR $15.23
- Revenue Next Year
- HSIC $3.70
- BRKR $7.52
- P/E Ratio
- HSIC $29.16
- BRKR $30.54
- Revenue Growth
- HSIC N/A
- BRKR 15.00
- 52 Week Low
- HSIC $63.67
- BRKR $48.07
- 52 Week High
- HSIC $82.63
- BRKR $94.86
- Technical
- Relative Strength Index (RSI)
- HSIC 49.61
- BRKR 58.41
- Support Level
- HSIC $69.10
- BRKR $58.78
- Resistance Level
- HSIC $72.67
- BRKR $64.64
- Average True Range (ATR)
- HSIC 1.50
- BRKR 1.98
- MACD
- HSIC 0.12
- BRKR 0.39
- Stochastic Oscillator
- HSIC 70.89
- BRKR 59.23
About HSIC Henry Schein Inc.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, pharmaceutical, and biotechnology industries. It operates in four operating segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from Asia Pacific.